Related Experiment Videos
Class specific antinuclear antibodies in systemic lupus erythematosus
K Savitri1, S Sehgal, B N Datta
1Department of Immunopathology, Postgraduate Institute of Medical Education & Research, Chandigarh.
The Indian Journal of Medical Research
|February 1, 1993
Summary
This study investigated antinuclear antibodies (ANA) in systemic lupus erythematosus patients. IgD ANA levels correlated with disease activity, while IgG ANA indicated lupus patterns and serositis.
Area of Science:
- Immunology
- Rheumatology
- Clinical Medicine
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- Antinuclear antibodies (ANA) are key biomarkers in SLE diagnosis.
- Understanding specific ANA subclasses and their clinical relevance is crucial for patient management.
Purpose of the Study:
- To investigate the incidence and significance of class-specific antinuclear antibodies (ANA) in SLE patients.
- To correlate ANA subclasses with clinical manifestations, including arthritis, renal disease, and serositis.
- To assess the relationship between ANA and overall disease activity.
Main Methods:
- Indirect immunofluorescence method was used to detect ANA.
- Forty patients diagnosed with systemic lupus erythematosus were included in the study.
- Clinical activity was quantified using Morimoto's scoring system.
Main Results:
- A significant correlation was observed between IgD ANA and the clinical activity of SLE.
- IgG ANA exhibiting a lupus pattern of immunofluorescence were significantly associated with serositis.
- The study identified specific ANA subclasses linked to distinct clinical features of the disease.
Conclusions:
- Class-specific ANA, particularly IgD and IgG ANA, serve as valuable indicators of disease activity and specific clinical manifestations in SLE.
- These findings highlight the importance of subclass-specific ANA testing for a more precise understanding of SLE pathology and patient prognosis.